While AI advancements like 3D tumor auto-segmentation and radiation therapy planning have been FDA-approved for adult oncology, pediatric standards were lacking. The AI-RAPNO policy and its companion ...

The U.S. Food and Drug Administration (FDA) has granted rare pediatric drug designation for iopofosine-131 in inoperable relapsed or refractory pediatric high-grade glioma (pHGG), according to a news ...

Team-based versus technology-based supportive cancer care (SCC): Implementation across 24 clinical settings. “If we don’t speak the language, we aren’t offered the same opportunities”: Qualitative ...

Parental insights into phase I pediatric oncology clinical trials: Findings from a phenomenological study. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This abstract does not ...

US v. Skrmetti undermined constitutional guardrails that guarantee rigorous assessment of medical justifications for policies limiting the rights of transgender people and women, creating a need and ...

Fractures in very young children that are not consistent with history or for which no history of injury is given are concerning for abuse. For children in whom abuse is suspected, a close examination ...

Please provide your email address to receive an email when new articles are posted on . The Research to Accelerate Cures and Equity Act led to an increase in required pediatric studies for recently ...

The U.S. Food and Drug Administration’s six-month pediatric exclusivity rules that apply to drugs also largely apply to biologics (albeit with certain distinctions), which may become a valuable life ...

U.S. hospitals vary widely in their readiness to provide high-quality emergency care for children, which translates into ...